Additionally, the inclusion criteria favoring tumors with higher invasion grades (pT3 and pT4) may not accurately reflect the behavior and prognostic implications of CDX2 expression in earlier stages of colon cancer. This evidence concerns the gene CDX2 and colonic neoplasm.